HCA Healthcare, Inc. $HCA Shares Bought by Focus Partners Wealth

Focus Partners Wealth lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,617 shares of the company’s stock after purchasing an additional 301 shares during the period. Focus Partners Wealth’s holdings in HCA Healthcare were worth $2,287,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Avantax Advisory Services Inc. increased its stake in shares of HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock valued at $2,791,000 after acquiring an additional 32 shares during the period. Glenview Trust co increased its stake in shares of HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC increased its stake in shares of HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after acquiring an additional 33 shares during the period. Catalyst Financial Partners LLC increased its stake in shares of HCA Healthcare by 4.3% during the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company’s stock valued at $301,000 after acquiring an additional 36 shares during the period. Finally, RWA Wealth Partners LLC increased its stake in shares of HCA Healthcare by 2.0% during the first quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock valued at $658,000 after acquiring an additional 37 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on HCA. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research note on Monday, July 28th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $403.17.

HCA Healthcare Stock Performance

NYSE:HCA opened at $399.79 on Wednesday. The firm’s 50-day moving average is $383.82 and its 200-day moving average is $364.30. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The company has a market cap of $93.55 billion, a price-to-earnings ratio of 16.80, a PEG ratio of 1.27 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.